Bivalirudin versus Heparin in Patients Undergoing Percutaneous Peripheral Interventions: A Systematic Review and Meta-analysis

Journal of the American College of Cardiology(2017)

Cited 5|Views9
No score
Abstract
Bivalirudin may be an effective anticoagulation alternative to heparin as anticoagulant agent in percutaneous peripheral interventions (PPI). We aimed to compare safety and efficacy of bivalirudin versus heparin as the procedural anticoagulant agent in patients undergoing PPI.We conducted an
More
Translated text
Key words
percutaneous peripheral interventions,heparin,systematic review,meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined